Synonym
Citreamicin alpha; LL E19085alpha; LL-E19085alpha; LLE19085alpha;
IUPAC/Chemical Name
(16-hydroxy-11,12-dimethoxy-1,1-dimethyl-2,8,14,15,17-pentaoxo-1,2,8,14,15,17-hexahydrochromeno[2',3':6,7]naphtho[2,1-g]oxazolo[3,2-b]isoquinolin-3a(4H)-yl)methyl 3-methylbutanoate
InChi Key
CWPZIGIUHZNJEJ-UHFFFAOYSA-N
InChi Code
InChI=1S/C36H31NO12/c1-15(2)9-23(38)47-14-36-13-17-10-16-7-8-18-26(24(16)30(41)25(17)33(43)37(36)35(3,4)34(44)49-36)31(42)27-28(39)19-11-21(45-5)22(46-6)12-20(19)48-32(27)29(18)40/h7-8,10-12,15,41H,9,13-14H2,1-6H3
SMILES Code
CC(C)CC(OCC(CC1=C2C(O)=C3C(C=CC(C(C4=C5C(C6=CC(OC)=C(OC)C=C6O4)=O)=O)=C3C5=O)=C1)(OC(C7(C)C)=O)N7C2=O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
669.63
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Qadri SM, Saldin H, Ueno Y, al-Ballaa SR. Antibacterial activity of citreamicin-alpha (LL-E 19085 alpha) against gram-positive cocci. Chemotherapy. 1992;38(6):395-8. PubMed PMID: 1288963.
2: Maiese WM, Lechevalier MP, Lechevalier HA, Korshalla J, Goodman J, Wildey MJ, Kuck N, Greenstein M. LL-E19085 alpha, a novel antibiotic from Micromonospora citrea: taxonomy, fermentation and biological activity. J Antibiot (Tokyo). 1989 Jun;42(6):846-51. PubMed PMID: 2661510.
3: Pearce CJ, Carter GT, Nietsche JA, Borders DB, Greenstein M, Maiese WM. The effect of methylation inhibitors on citreamicin biosynthesis in Micromonospora citrea. J Antibiot (Tokyo). 1991 Nov;44(11):1247-51. PubMed PMID: 1761421.
4: Carter GT, Nietsche JA, Williams DR, Borders DB. Citreamicins, novel antibiotics from Micromonospora citrea: isolation, characterization, and structure determination. J Antibiot (Tokyo). 1990 May;43(5):504-12. PubMed PMID: 2358403.